• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

岩藻聚糖硫酸酯通过改善肝脏氧化应激和肠道微生物群组成缓解高脂饮食诱导的肥胖和胰岛素抵抗。

Fucoidan Alleviates High-Fat Diet-Induced Obesity and Insulin Resistance Associated with the Improvement of Hepatic Oxidative Stress and Gut Microbiota Profile.

机构信息

College of Life and Environmental Science, Wenzhou University, Wenzhou 325035, China.

Environmental Science and Environmental Engineering, University of Northern British Columbia, Prince George, British Columbia, Canada V2N 4Z9.

出版信息

J Agric Food Chem. 2020 Sep 30;68(39):10626-10638. doi: 10.1021/acs.jafc.0c02555. Epub 2020 Sep 10.

DOI:10.1021/acs.jafc.0c02555
PMID:32866006
Abstract

fucoidan (SFF) exhibits diverse biological activities. Insulin resistance (IR) implicated in type 2 diabetes (T2D) has become an epidemic health issue worldwide. In this study, we investigated whether SFF can improve insulin sensitivity in high-fat diet (HFD)-fed mice. Our present data showed that SFF significantly reduced fasting blood glucose and IR index along with improved glucose tolerance. Impaired phosphorylation of Akt was also restored by SFF. Furthermore, SFF decreased the levels of MDA and 4-HNE-modified protein and increased GSH/GSSG ratio as well as elevated antioxidant enzymes and activated Nrf2 signaling. SFF also increased the abundance and diversity of gut microbiota in the obese mice, as well as improved intestinal integrity and inflammation. Our findings suggested that SFF ameliorated HFD-induced IR through activating the Nrf2 pathway, remodeling gut microbiota, and reducing intestinal inflammation, thus providing a novel perspective into the treatment strategy on metabolic disease.

摘要

岩藻聚糖硫酸酯(SFF)具有多种生物学活性。2 型糖尿病(T2D)中涉及的胰岛素抵抗(IR)已成为全球范围内的流行健康问题。在这项研究中,我们研究了 SFF 是否可以改善高脂肪饮食(HFD)喂养的小鼠的胰岛素敏感性。我们目前的数据表明,SFF 可显著降低空腹血糖和 IR 指数,改善葡萄糖耐量。SFF 还恢复了 Akt 的磷酸化。此外,SFF 降低了 MDA 和 4-HNE 修饰蛋白的水平,增加了 GSH/GSSG 比值,并提高了抗氧化酶的活性和 Nrf2 信号通路的激活。SFF 还增加了肥胖小鼠肠道微生物群的丰度和多样性,改善了肠道完整性和炎症。我们的研究结果表明,SFF 通过激活 Nrf2 通路、重塑肠道微生物群和减少肠道炎症来改善 HFD 诱导的 IR,从而为代谢性疾病的治疗策略提供了新的视角。

相似文献

1
Fucoidan Alleviates High-Fat Diet-Induced Obesity and Insulin Resistance Associated with the Improvement of Hepatic Oxidative Stress and Gut Microbiota Profile.岩藻聚糖硫酸酯通过改善肝脏氧化应激和肠道微生物群组成缓解高脂饮食诱导的肥胖和胰岛素抵抗。
J Agric Food Chem. 2020 Sep 30;68(39):10626-10638. doi: 10.1021/acs.jafc.0c02555. Epub 2020 Sep 10.
2
fucoidan alleviates diet-induced insulin resistance by inhibiting colon-derived ceramide biosynthesis.褐藻糖胶通过抑制结肠衍生神经酰胺生物合成缓解饮食诱导的胰岛素抵抗。
Food Funct. 2021 Sep 20;12(18):8440-8453. doi: 10.1039/d1fo01272j.
3
fucoidan modifies gut microbiota and intestinal metabolites during alleviation of hyperglycemia in type 2 diabetic mice.褐藻糖胶在改善 2 型糖尿病小鼠高血糖的过程中改变了肠道微生物群和肠道代谢物。
Food Funct. 2021 Apr 26;12(8):3572-3585. doi: 10.1039/d0fo03329d.
4
Sargassum fusiforme fucoidan modifies the gut microbiota during alleviation of streptozotocin-induced hyperglycemia in mice.半叶马尾藻岩藻聚糖硫酸酯通过调节肠道微生物群缓解链脲佐菌素诱导的小鼠高血糖。
Int J Biol Macromol. 2019 Jun 15;131:1162-1170. doi: 10.1016/j.ijbiomac.2019.04.040. Epub 2019 Apr 8.
5
Sargassum fusiforme fucoidan ameliorates diet-induced obesity through enhancing thermogenesis of adipose tissues and modulating gut microbiota.半叶马尾藻岩藻聚糖硫酸酯通过增强脂肪组织的产热作用和调节肠道微生物群来改善饮食诱导的肥胖。
Int J Biol Macromol. 2022 Sep 1;216:728-740. doi: 10.1016/j.ijbiomac.2022.07.184. Epub 2022 Jul 28.
6
Sargassum fusiforme together with turmeric extract and pomegranate peel extract alleviates obesity in high fat-fed C57BL/6J mice.马尾藻提取物、姜黄提取物和石榴皮提取物联合减轻高脂喂养 C57BL/6J 小鼠肥胖。
Food Funct. 2021 May 21;12(10):4654-4669. doi: 10.1039/d0fo03044a. Epub 2021 Apr 29.
7
A fucoidan from Sargassum fusiforme with novel structure and its regulatory effects on intestinal microbiota in high-fat diet-fed mice.一种来源于羊栖菜的具有新颖结构的岩藻聚糖硫酸酯及其对高脂饮食喂养小鼠肠道微生物群的调节作用。
Food Chem. 2021 Oct 1;358:129908. doi: 10.1016/j.foodchem.2021.129908. Epub 2021 Apr 20.
8
Codonopsis lanceolata polysaccharide CLPS alleviates high fat/high sucrose diet-induced insulin resistance via anti-oxidative stress.党参多糖 CLPS 通过抗氧化应激缓解高脂/高蔗糖饮食诱导的胰岛素抵抗。
Int J Biol Macromol. 2020 Feb 15;145:944-949. doi: 10.1016/j.ijbiomac.2019.09.185. Epub 2019 Oct 24.
9
Sargassum fusiforme Polysaccharide Rejuvenat es the Small Intestine in Mice Through Altering its Physiol ogy and Gut Microbiota Composition.半叶马尾藻多糖通过改变其生理学和肠道微生物组成使小鼠小肠年轻化。
Curr Mol Med. 2017;17(5):350-358. doi: 10.2174/1566524018666171205115516.
10
Comparative Study of Polysaccharides in Regulating Cecal and Fecal Microbiota of High-Fat Diet-Fed Mice.高脂饮食喂养小鼠盲肠和粪便微生物群调节的多糖比较研究。
Mar Drugs. 2021 Jun 24;19(7):364. doi: 10.3390/md19070364.

引用本文的文献

1
Anti-Obesity Mechanisms of Plant and Fungal Polysaccharides: The Impact of Structural Diversity.植物和真菌多糖的抗肥胖机制:结构多样性的影响
Biomolecules. 2025 Aug 7;15(8):1140. doi: 10.3390/biom15081140.
2
Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review.肠道微生物群与代谢性疾病中天然生物活性多糖的相互作用:综述。
Nutrients. 2024 Aug 24;16(17):2838. doi: 10.3390/nu16172838.
3
Effects of fucoidan and synbiotics supplementation during bismuth quadruple therapy of infection on gut microbial homeostasis: an open-label, randomized clinical trial.
岩藻多糖和合生元补充剂在铋四联疗法治疗幽门螺杆菌感染期间对肠道微生物稳态的影响:一项开放标签、随机临床试验。
Front Nutr. 2024 Jul 1;11:1407736. doi: 10.3389/fnut.2024.1407736. eCollection 2024.
4
Antioxidative and Anti-inflammatory Effects of Plant-derived Hypoglycemic Medicines: An Systematic Review.植物源降血糖药物的抗氧化和抗炎作用:系统评价。
Curr Top Med Chem. 2024;24(16):1408-1450. doi: 10.2174/0115680266295032240415064750.
5
Advances in molecular mechanisms and therapeutic strategies for central nervous system diseases based on gut microbiota imbalance.基于肠道微生物群失衡的中枢神经系统疾病分子机制及治疗策略进展
J Adv Res. 2025 Mar;69:261-278. doi: 10.1016/j.jare.2024.03.023. Epub 2024 Apr 3.
6
Recent advances in the extraction, purification, structural-property correlations, and antiobesity mechanism of traditional Chinese medicine-derived polysaccharides: a review.中药来源多糖的提取、纯化、结构-性质关系及抗肥胖机制的研究进展:综述
Front Nutr. 2024 Jan 17;10:1341583. doi: 10.3389/fnut.2023.1341583. eCollection 2023.
7
Notoginsenoside-R1 ameliorates palmitic acid-induced insulin resistance and oxidative stress in HUVEC via Nrf2/ARE pathway.三七皂苷-R1通过Nrf2/ARE途径改善棕榈酸诱导的人脐静脉内皮细胞胰岛素抵抗和氧化应激。
Food Sci Nutr. 2023 Oct 18;11(12):7791-7802. doi: 10.1002/fsn3.3696. eCollection 2023 Dec.
8
Potential Application of Marine Fucosyl-Polysaccharides in Regulating Blood Glucose and Hyperglycemic Complications.海洋岩藻糖基多糖在调节血糖及高血糖并发症方面的潜在应用
Foods. 2023 Jul 5;12(13):2600. doi: 10.3390/foods12132600.
9
Beneficial effects of seaweed-derived components on metabolic syndrome via gut microbiota modulation.海藻衍生成分通过调节肠道微生物群对代谢综合征的有益作用。
Front Nutr. 2023 Jun 15;10:1173225. doi: 10.3389/fnut.2023.1173225. eCollection 2023.
10
Roles of Marine Macroalgae or Seaweeds and Their Bioactive Compounds in Combating Overweight, Obesity and Diabetes: A Comprehensive Review.海洋大型藻类或海藻及其生物活性化合物在防治超重、肥胖和糖尿病中的作用:全面综述。
Mar Drugs. 2023 Apr 21;21(4):258. doi: 10.3390/md21040258.